A retrospective series of gut aspergillosis in haematology patients

Clinical Microbiology and Infection

Volumn 17, Issue 4, 2011, Pages 588-594

  Kazan, E ^a   Maertens, J ^b   Herbrecht, R ^c   Weisser, M ^d   Gachot, B ^e   Vekhoff, A ^f   Caillot, D ^g   Raffoux, E ^h   Fagot, T ⁱ   Reman, O ^j   Isnard, F ^k   Thiebaut, A ^l   Bretagne, S ^a   Cordonnier, C ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f HÔTEL DIEU   (France)

^g HÔPITAL DU BOCAGE   (France)

^h UNIVERSITÉ PARIS DESCARTES   (France)

ⁱ Haematology Department   (France)

^j CAEN UNIVERSITY HOSPITAL   (France)

^k HÔPITAL SAINT ANTOINE   (France)

^l GRENOBLE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Acute leukaemia; Gut infection; Invasive aspergillosis; Stem cell transplantation

Indexed keywords

GALACTOMANNAN;

ACUTE LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; CANCER PATIENT; CLINICAL ARTICLE; DIETARY INTAKE; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC DISEASE; HUMAN; INTESTINE INFECTION; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SPICE;

ASPERGILLUS;

EID: 79952733461     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03310.x     Document Type: Article

References (17)

1. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366.
2. Hori A, Kami M, Kishi Y, Machida U, Matsumura T, Kashima T. Clinical significance of extra-pulmonary involvement of invasive aspergillosis: a retrospective autopsy-based study of 107 patients. J Hosp Infect 2002; 50: 175-182.
3. Prescott RJ, Harris M, Banerjee SS. Fungal infections of the small and large intestine. J Clin Pathol 1992; 45: 806-811.
4. Davies S. Aspergillosis in the immunocompromised patient. Springfield, IL: Thomas, 1985.
5. Eggimann P, Chevrolet JC, Starobinski M et al. Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature. Infection 2006; 34: 333-338.
6. De Pauw B, Walsh T, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis 2008; 46: 1813-1821.
7. Segal B, Herbrecht R, Stevens DA et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 2008; 47: 674-683.
8. Chambon-Pautas C, Costa JM, Chaumette MT, Cordonnier C, Bretagne S. Galactomannan and polymerase chain reaction for the diagnosis of primary digestive aspergillosis in a patient with acute myeloid leukaemia. J Infect 2001; 43: 213-214.
9. Elvira CRd. Med-AB Forms Manual: a guide to the completion of the EBMT HSCT Med-AB forms. Appendix iii. In EBMT registry: User guide to Promise 2.2, 23 September 2009.
10. De Bock R, Gyssens I, Peetermans M, Nolard N. Aspergillus in pepper. Lancet 1989; 2: 331-332.
11. Boon AP, O'Brien D, Adams DH. 10 year review of invasive aspergillosis detected at necropsy. J Clin Pathol 1991; 44: 452-454.
12. Vogeser M, Haas A, Aust D, Ruckdeschel G. Postmortem analysis of invasive aspergillosis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 1997; 16: 1-6.
13. Vogeser M, Wanders A, Haas A, Ruckdeschel G. A four-year review of fatal aspergillosis. Eur J Clin Microbiol Infect Dis 1999; 18: 42-45.
14. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990; 12: 1147-1201.
15. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-415.
16. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-1610.
17. Woods G, Miceli MH, Grazziutti ML, Zhao W, Barlogie B, Anaissie E. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer 2007; 110: 830-834.